Pyxis Oncology Inc. (PYXS) PT Lowered to $8; RBC Capital: 'We Would Be Buyers into 2025 Data'
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev lowered the price target on Pyxis Oncology Inc. (NASDAQ: PYXS) to $8.00 (from $10.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
